SCHEMBL6396231

SCHEMBL6396231

CCOC(C)COCC(C)O

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57
HSD17B10 Q99714 1/20 0.50
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.36
TSHR P16473 1/20 0.35
THRB P10828 1/20 0.33
KDM4E B2RXH2 1/20 0.32
FYN P06241 1/20 0.31
MAOA P21397 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2C P28335 1/20 0.31
HTR2B P41595 1/20 0.31
SLC6A3 Q01959 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9622081 0.87 LMNA (0.47) TDP1HSD17B10LMNATHRB
SCHEMBL811380 0.85 TDP1 (0.68) TDP1HSD17B10LMNAMAPK1TSHR
SCHEMBL9389743 0.84 TDP1 (0.67) TDP1HSD17B10LMNAMAPK1TSHR
SCHEMBL18082478 0.83 TDP1 (0.59) TDP1HSD17B10LMNAMAPK1TSHR
SCHEMBL10021836 0.83 TDP1 (0.65) TDP1HSD17B10LMNAMAPK1TSHR
SCHEMBL43392 0.82 TDP1 (0.71) TDP1HSD17B10LMNAMAPK1TSHR
SCHEMBL28426892 0.82 TDP1 (0.46) TDP1LMNATHRB
SCHEMBL5320748 0.82 TDP1 (0.70) TDP1HSD17B10MAPK1TSHRKDM4E
SCHEMBL15973 0.81 TDP1 (0.69) TDP1HSD17B10LMNAMAPK1TSHR
SCHEMBL27646137 0.80 LMNA (0.41) TDP1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117738572-A Intelligent window with adjustable light transmittance 浙江华帅特新材料科技有限公司 2024-03-22 CN claimed
EP-3720835-B1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2022-07-13 EP claimed
US-11078146-B2 Method for preparing ethers of cycloaliphatic or araliphatic diols BASF SE (DE) 2021-08-03 US claimed
US-20210171427-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2021-06-10 US claimed
EP-3720835-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2020-10-14 EP claimed
CN-111479795-A Process for preparing ethers of cycloaliphatic or araliphatic diols 巴斯夫欧洲公司 2020-07-31 CN claimed
WO-2019110464-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2019-06-13 WO claimed
CN-109486282-A Ink for black ink box of ink-jet printer preparation method 周利平 2019-03-19 CN claimed
CN-107353709-A Printer ink processing technology 周利平 2017-11-17 CN claimed
CN-107201081-A Printer ink-manufacturing method 周利军 2017-09-26 CN claimed
CN-106810944-A Printer ink-manufacturing method 周利军 2017-06-09 CN claimed
CN-106752343-A Ink for black ink box of ink-jet printer preparation method 周利平 2017-05-31 CN claimed
CN-117738572-A Intelligent window with adjustable light transmittance 浙江华帅特新材料科技有限公司 2024-03-22 CN disclosed
EP-3419588-B1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC (US) 2023-04-05 EP disclosed
WO-2023002847-A1 OIL DISPERSION COMPOSITION 株式会社 資生堂 2023-01-26 WO disclosed
WO-2022259917-A1 CLEANING AGENT COMPOSITION 株式会社 資生堂 2022-12-15 WO disclosed
EP-0897901-B1 Solution for forming ferroelectric film and method for forming ferroelectric film ROHM CO LTD (JP) 2003-11-05 EP disclosed
US-6485779-B1 Solution for forming ferroelectric film and method for forming ferroelectric film ROHM CO., LTD (JP) 2002-11-26 US disclosed
US-6086665-A Solution for forming ferroelectric film and method for forming ferroelectric film ROHM CO., LTD. (JP) 2000-07-11 US disclosed
EP-0897901-A1 Solution for forming ferroelectric film and method for forming ferroelectric film ROHM CO., LTD. (JP) 1999-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171427-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS DGKI, MGLL, DEGS1 TDP1 4346/4885HSD17B10 571/4885LMNA 1038/4885
US-11078146-B2 Method for preparing ethers of cycloaliphatic or araliphatic diols DGKI, MGLL, DEGS1 TDP1 4346/4885HSD17B10 571/4885LMNA 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.